聚合物填充环内移植物降低近端瘤颈扩张与移位的发生率
本研究基于前瞻性国际多中心Ovation支架移植物试验,纳入238例EVAR患者,随访中位58个月,发现尽管46%患者解剖条件挑战,仅4.2%发生近端瘤颈扩张,无移植物移位。
要点
- Ovation聚合物环内移植物5年免于近端瘤颈扩张率为93.6%。
- 挑战性解剖(46%)下仍仅4.2%发生瘤颈扩张,无移位。
- 聚合物环设计可能解释其优于自膨胀支架预防瘤颈扩张。
核心结论
- Ovation支架移植物在挑战性瘤颈解剖中仍与低近端瘤颈扩张率相关,且未观察到移植物移位。
研究设计与样本
- 前瞻性、国际、多中心Ovation支架移植物试验,纳入238例接受EVAR的患者。
- 临床事件委员会裁定1年不良事件,独立影像核心实验室分析5年影像,数据安全监测委员会监督。
主要发现
- 238例患者中男性81%,平均年龄73±8岁,中位随访58个月(IQR 36-60)。
- 46%患者具有挑战性解剖(超出其他市售支架移植物IFU),17.2%近端瘤颈长度<10 mm,39%最小入路血管直径<6 mm。
- 技术成功率100%,1、3、5年总生存率分别为96.6%、86.2%、74.9%。
- 术后即刻近端瘤颈直径16-31 mm,平均22.4±3 mm;随访中10例(4.2%)发生近端瘤颈扩张(≥3 mm)。
- 1、3、5年免于近端瘤颈扩张率分别为97.7%、96%、93.6%;无患者发生移植物移位。
关键数值与推荐
- 近端瘤颈扩张定义为瘤颈直径增大≥3 mm,于最低肾动脉水平测量。
- 移植物移位定义为远端移动>10 mm,或移动≤10 mm但导致二次干预。
临床怎么用
- 对于近端瘤颈解剖挑战的患者,可考虑使用Ovation聚合物环内移植物以降低瘤颈扩张和移位风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Proximal aortic neck dilatation (PND) affects a considerable proportion of patients undergoing endovascular aneurysm repair (EVAR) and is associated with increased rates of type I endoleak (EL1), migration, and reinterventions. Although there are numerous studies investigating PND following the placement of endografts that utilize self-expanding stent (SES) technology, there are few reports for patients treated with endografts that utilize polymer-filled rings. The purpose of this study is to examine PND and graft migration after EVAR with the Ovation stent graft. METHODS: The study comprised patients who underwent EVAR as part of the prospective, international, multicenter Ovation stent graft trial. A clinical events committee adjudicated adverse events through 1 year, an independent imaging core laboratory analyzed imaging through 5 years, and a data safety and monitoring board provided study oversight. Neck diameter was measured at the level of the lowest renal artery. PND was defined as neck enlargement of 3 mm or more. Graft migration was defined as distal movement >10 mm or movement ≤10 mm when resulting in secondary intervention. RESULTS: A total of 238 patients received this device during the study period. Patients were predominantly male (81%), with a mean age of 73 ± 8 years. Median follow-up was 58 months (IQR 36-60). Almost half the patients (110 patients, 46%) had challenging anatomy; defined as outside the instructions for use (IFU) with other commercially available stent grafts. 41 patients (17.2%) had a proximal neck length <10 mm and 93 (39%) had a minimum access vessel diameter <6 mm. The technical success rate was 100%. The 1-, 3- and 5-year overall survival rates were 96.6%, 86.2% and 74.9%, respectively. The immediate postoperative proximal neck diameter ranged from 16 mm to 31 mm with a mean of 22.4 ± 3 mm. During follow-up, ten patients (4.2%) developed PND. Freedom from PND estimates at 1, 3 and 5 years were 97.7%, 96%, and 93.6%, respectively. None of the patients developed endograft migration. CONCLUSIONS: The use of the Ovation stent graft was associated with low rates of PND despite challenging neck anatomy in 17% of patients. No graft migration was observed. The design of this endograft may explain its superiority to SES in preventing neck dilatation and migration even in patients with challenging neck anatomy. This is important, as we continue to see significant late failures of EVAR due to proximal neck degeneration.
引用
- Mathlouthi A, Yei K, Barleben A, et al. Polymer based endografts have improved rates of proximal aortic neck dilatation and migration. Ann Vasc Surg. 2021. PMID: 34411676. doi:10.1016/j.avsg.2021.05.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。